Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Both Novo Nordisk and Merck offer manufacturer copay cards that can reduce out-of-pocket costs sometimes to as low as $25 per fill for eligible commercially insured patients
Review Your Options Discuss insurance coverage, brand-name prescriptions, self-pay programs, alternatives and expected costs
Ozempic (SEMAGLUTIDE) FDA approval history
The biotech bagged $632.5 million to further develop VK2735 as well as its X-linked adrenoleukodystrophy and MASH drugs, which are in phase 1b and 2b trials, respectively, in 2024
June 22, 2025
US$ 22.94
US$ 20.56
US$ 27.38
US$ 23.62
US$ 24.76
